| The Center For Collaborative Counseling And Psychiatry | |
|
2401 Harnish Dr Ste 100 Algonquin IL 60102-6846 | |
| (847) 440-2281 | |
| (224) 241-8394 |
| Full Name | The Center For Collaborative Counseling And Psychiatry |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 2401 Harnish Dr Ste 100, Algonquin, Illinois |
| Authorized Official Name and Position | Joseph Mcnally (PRESIDENT) |
| Authorized Official Contact | 8474402281 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| The Center For Collaborative Counseling And Psychiatry 2401 Harnish Dr Ste 100 Algonquin IL 60102-6846 Ph: (847) 440-2281 | The Center For Collaborative Counseling And Psychiatry 2401 Harnish Dr Ste 100 Algonquin IL 60102-6846 Ph: (847) 440-2281 |
| NPI Number | 1457605057 |
|---|---|
| Provider Enumeration Date | 11/04/2012 |
| Last Update Date | 10/12/2023 |
| Certification Date | 10/12/2023 |
| Medicare PECOS PAC ID | 8224270954 |
|---|---|
| Medicare Enrollment ID | O20130809000041 |
News Archive
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.
GlobalOptions Group, Inc., a leading provider of domestic and international risk management services, affirmed today that James Lee Witt Associates (JLWA), its Crisis Management and Preparedness Services Division, supports the recommendations of a report developed by The Children's Health Fund (CHF) to modify the National Response Framework to include issues addressing case management for children.
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Actor Simon Callow and author Stephen Fry are backing a poetry anthology for the NHS Covid-19 Emergency Fund which includes a poem by Dr Emma Halliday of Lancaster University.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457605057 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 071006833 (Illinois) | Secondary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 036088742 (Illinois) | Primary |
| Provider Name | Joseph P Mcnally |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679540595 PECOS PAC ID: 1456301670 Enrollment ID: I20050126000439 |
News Archive
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.
GlobalOptions Group, Inc., a leading provider of domestic and international risk management services, affirmed today that James Lee Witt Associates (JLWA), its Crisis Management and Preparedness Services Division, supports the recommendations of a report developed by The Children's Health Fund (CHF) to modify the National Response Framework to include issues addressing case management for children.
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Actor Simon Callow and author Stephen Fry are backing a poetry anthology for the NHS Covid-19 Emergency Fund which includes a poem by Dr Emma Halliday of Lancaster University.
› Verified 4 days ago
| Provider Name | Michael D Gara |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1184833931 PECOS PAC ID: 7719162676 Enrollment ID: I20110420000064 |
News Archive
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.
GlobalOptions Group, Inc., a leading provider of domestic and international risk management services, affirmed today that James Lee Witt Associates (JLWA), its Crisis Management and Preparedness Services Division, supports the recommendations of a report developed by The Children's Health Fund (CHF) to modify the National Response Framework to include issues addressing case management for children.
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Actor Simon Callow and author Stephen Fry are backing a poetry anthology for the NHS Covid-19 Emergency Fund which includes a poem by Dr Emma Halliday of Lancaster University.
› Verified 4 days ago
News Archive
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.
GlobalOptions Group, Inc., a leading provider of domestic and international risk management services, affirmed today that James Lee Witt Associates (JLWA), its Crisis Management and Preparedness Services Division, supports the recommendations of a report developed by The Children's Health Fund (CHF) to modify the National Response Framework to include issues addressing case management for children.
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Actor Simon Callow and author Stephen Fry are backing a poetry anthology for the NHS Covid-19 Emergency Fund which includes a poem by Dr Emma Halliday of Lancaster University.
› Verified 4 days ago
Rosecrans & Associates Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1457 Merchant Dr Ste C, Algonquin, IL 60102 Phone: 847-461-8414 Fax: 847-461-8387 | |
Work With Families Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10075 N River Rd, Algonquin, IL 60102 Phone: 847-770-3484 Fax: 847-658-3446 | |
Infinity Center For Personal Growth Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1489 Merchant Dr, Algonquin, IL 60102 Phone: 815-444-9700 Fax: 224-304-4664 | |
Thomson Memory Center Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1451 Merchant Dr, Algonquin, IL 60102 Phone: 847-469-7537 Fax: 847-469-7540 | |
Cpeters01 Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1138 N Main St, Algonquin, IL 60102 Phone: 773-960-7706 | |
Algonquin Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1473 Commerce Dr, Algonquin, IL 60102 Phone: 847-662-4380 Fax: 847-662-3557 | |
Epp Advisory Group Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 265 Stonegate Rd Ste 102, Algonquin, IL 60102 Phone: 224-678-9180 Fax: 224-678-9369 |